Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 484Glioma 227Glioblastoma 223Neoplasms 62Neuroblastoma 56Central Nervous System Neoplasms 56Breast Neoplasms 54Meningioma 48Astrocytoma 42Neuroma, Acoustic 38Spinal Cord Neoplasms 35Neurofibromatosis 1 32Sarcoma 29Lung Neoplasms 29Oligodendroglioma 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 27Neoplasm Metastasis 26Head and Neck Neoplasms 25Melanoma 22Lymphoma, Non-Hodgkin 22Leukemia 22Meningeal Carcinomatosis 21Medulloblastoma 21Hodgkin Disease 21Burkitt Lymphoma 20Testicular Neoplasms 19Lymphoma, Follicular 19Multiple Myeloma 18Gliosarcoma 18

Interventions

Gadolinium 1Ferrosoferric Oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Adult Brain Glioblastoma × CNS × Clear all
NCT00660543 2017-05-16

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

OHSU Knight Cancer Institute

Phase NA Completed
14 enrolled 6 charts
CNS

Adult Brain Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡